|
USP5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.97379999997438E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.333600E-02 |
| Normal-vs-Stage2 |
2.786200E-01 |
| Normal-vs-Stage3 |
6.767000E-04 |
| Normal-vs-Stage4 |
1.004830E-01 |
| Stage1-vs-Stage2 |
9.037800E-01 |
| Stage1-vs-Stage3 |
9.095300E-03 |
| Stage1-vs-Stage4 |
2.385800E-01 |
| Stage2-vs-Stage3 |
6.462200E-02 |
| Stage2-vs-Stage4 |
2.438200E-01 |
| Stage3-vs-Stage4 |
8.559400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.07459999999449E-05 |
| Normal-vs-AfricanAmerican |
1.390060E-02 |
| Normal-vs-Asian |
3.777800E-01 |
| Caucasian-vs-AfricanAmerican |
7.357000E-01 |
| Caucasian-vs-Asian |
7.648400E-01 |
| AfricanAmerican-vs-Asian |
6.848600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.996000E-04 |
| Normal-vs-Female |
1.53944999999878E-05 |
| Male-vs-Female |
2.628400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.854300E-02 |
| Normal-vs-Extreme_Weight |
1.199220E-01 |
| Normal-vs-Obese |
5.006000E-04 |
| Normal-vs-Extreme_Obese |
8.096800E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.048000E-01 |
| Normal_Weight-vs-Obese |
6.023200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.024800E-01 |
| Extreme_Weight-vs-Obese |
6.763500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.190400E-01 |
| Obese-vs-Extreme_Obese |
1.999780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.35630000008824E-07 |
| Normal-vs-Age(41-60Yrs) |
4.445400E-04 |
| Normal-vs-Age(61-80Yrs) |
1.456130E-03 |
| Normal-vs-Age(81-100Yrs) |
3.288000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.588400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.904500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.089700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.442400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.991800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.668600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.617500E-04 |
| Normal-VS-Type2 PRCC |
1.496870E-03 |
| Normal-VS-KIRP CIMP |
9.300500E-02 |
| Normal-VS-Unclassified PRCC |
1.520020E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.970600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.622400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.771700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.406200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.610800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.276000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.158840E-01 |
| Normal-vs-N1 |
4.003800E-03 |
| Normal-vs-N2 |
3.134500E-02 |
| N0-vs-N1 |
3.657700E-02 |
| N0-vs-N2 |
3.561600E-03 |
| N1-vs-N2 |
1.305210E-01 |
|
|
